ARTERRA BIOSCIENCE SPA (ARBS.MI) Stock Price & Overview
BIT:ARBS • IT0005386369
Current stock price
The current stock price of ARBS.MI is 3.13 EUR. Today ARBS.MI is up by 15.07%. In the past month the price decreased by -0.64%.
ARBS.MI Key Statistics
- Market Cap
- 20.846M
- P/E
- 10.43
- Fwd P/E
- N/A
- EPS (TTM)
- 0.30
- Dividend Yield
- 4.93%
ARBS.MI Stock Performance
ARBS.MI Stock Chart
ARBS.MI Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to ARBS.MI.
ARBS.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to ARBS.MI. ARBS.MI scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
ARBS.MI Earnings
ARBS.MI Forecast & Estimates
7 analysts have analysed ARBS.MI and the average price target is 3.88 EUR. This implies a price increase of 23.83% is expected in the next year compared to the current price of 3.13.
ARBS.MI Groups
Sector & Classification
ARBS.MI Financial Highlights
Over the last trailing twelve months ARBS.MI reported a non-GAAP Earnings per Share(EPS) of 0.3. The EPS increased by 37.48% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 42.38% | ||
| ROA | 13.59% | ||
| ROE | 16.33% | ||
| Debt/Equity | 0.02 |
ARBS.MI Ownership
ARBS.MI Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ARGX | ARGENX SE | 29.64 | 42.19B | ||
| 1AE | ARGENX SE | 29.31 | 42.152B | ||
| 22UA | BIONTECH SE-ADR | N/A | 23.973B | ||
| ABVX | ABIVAX SA | N/A | 7.862B | ||
| 2X1 | ABIVAX SA | N/A | 7.834B | ||
| GXE | GALAPAGOS NV | N/A | 1.637B | ||
| GLPG | GALAPAGOS NV | N/A | 1.636B | ||
| NANO | NANOBIOTIX | N/A | 1.308B | ||
| PHARM | PHARMING GROUP NV | 47.98 | 1.018B | ||
| 6IV | INVENTIVA SA | N/A | 990.777M | ||
| PHGN | PHARMING GROUP NV | 45.76 | 976.038M | ||
| DBV | DBV TECHNOLOGIES SA | N/A | 951.4M | ||
| IVA | INVENTIVA SA | N/A | 947.158M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Milan Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About ARBS.MI
Company Profile
Arterra Bioscience SpA is engaged in research and development activities in the field of living organisms such as bacteria, yeasts, and plant and animal cells. The company is headquartered in Naples, Napoli and currently employs 37 full-time employees. The company went IPO on 2019-10-28. The firm focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Company’s main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The firm collaborates with private companies, universities and research institutes all over the world.
Company Info
IPO: 2019-10-28
ARTERRA BIOSCIENCE SPA
via Benedetto Brin, 69
Naples NAPOLI IT
Employees: 34
Phone: 390816584411
ARTERRA BIOSCIENCE SPA / ARBS.MI FAQ
Can you describe the business of ARTERRA BIOSCIENCE SPA?
Arterra Bioscience SpA is engaged in research and development activities in the field of living organisms such as bacteria, yeasts, and plant and animal cells. The company is headquartered in Naples, Napoli and currently employs 37 full-time employees. The company went IPO on 2019-10-28. The firm focuses on research and development of ingredients and natural solutions. By exploiting the potentialities of living organisms such as bacteria, yeasts, plants and animal cells, the Company develops products and processes that serve as enabling technologies and that find horizontal application in various industrial sectors, such as cosmetics, agriculture and nutraceutics. The Company’s main activities and applications include development of technological platforms, employed in the screening of active compounds for different industrial applications; setting up of new extraction processes, aimed at improving the sustainability and yield of interesting compounds and the production of high-tech raw materials with application in different industrial fields. The firm collaborates with private companies, universities and research institutes all over the world.
What is the stock price of ARTERRA BIOSCIENCE SPA today?
The current stock price of ARBS.MI is 3.13 EUR. The price increased by 15.07% in the last trading session.
Does ARTERRA BIOSCIENCE SPA pay dividends?
ARTERRA BIOSCIENCE SPA (ARBS.MI) has a dividend yield of 4.93%. The yearly dividend amount is currently 0.11.
How is the ChartMill rating for ARTERRA BIOSCIENCE SPA?
ARBS.MI has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
How is the valuation of ARTERRA BIOSCIENCE SPA (ARBS.MI) based on its PE ratio?
The PE ratio for ARTERRA BIOSCIENCE SPA (ARBS.MI) is 10.43. This is based on the reported non-GAAP earnings per share of 0.3 and the current share price of 3.13 EUR.
How many employees does ARTERRA BIOSCIENCE SPA have?
ARTERRA BIOSCIENCE SPA (ARBS.MI) currently has 34 employees.